A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors

NCT06043466 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer
Esophagus Cancer
Gastric Cancer
Pancreas Cancer
Non-small Cell Lung Cancer
Breast Cancer
Bile Duct Cancer

Interventions

BIOLOGICAL: CEA-targeted CAR-T cells

Sponsor

Chongqing Precision Biotech Co., Ltd

Collaborators

[object Object]